Treating Dairy Cows at Calving with EPRINEX^®

Results from a variety of studies have been used to support the simulator. A key study involved was a large multi-centric study conducted in Australia. Other studies utilised were conducted in Australia, NZ and around the world. These studies prove that there are potential economic benefits from treating dairy cows at or around calving.

The key Australian study was the third largest of it's kind undertaken. It demonstrated that usage of IVOMEC EPRINEX at or around calving can result in an increase of 63L of milk per cow over a full lactation. In addition, another supportive study has been published in the NZ Veterinary Journal. Such details provide testament to the depth and quality of the trial work supporting this simulator.

Using the simulator you can calculate the potential economic benefit of treating Dairy Cows at or around calving with IVOMEC EPRINEX. All you need to do is insert your relevant data below and then click on the Recalculate Profit button.

A number of assumptions have been utilised to make this simulator as user-friendly as possible. These include figures relating to product price, yields during various stages of lactation and timing of dosing.

For a more detailed appraisal of how you can achieve productivity benefits such as those described in this simulator we recommend that you contact Merial Australia by viewing our Contact Us page.

The potential returns above include the following:
The potential profit available is due both to an increase in milk output per day per cow as well as to an increase in the number of days extra milking possible due to the cows getting in calf quicker. As an example, the Australian studies referred to above demonstrated that each cow could produce an average of 63L extra milk and potentially milk an extra 4.8 days as a result of the treatments given, leading up to and around the time of calving.

To calculate the final additional income figure these two sources of benefits are combined with certain assumptions and the figures that are provided above by you. It must be noted that improvements in milk fat and protein are not included in the calculations, despite being significantly increased in those studies conducted that assessed the changes in fat and protein levels following IVOMEC EPRINEX administration.

Note: Financial figures depicted within the simulator refer to potential profit and are indicative only. They describe typical potential returns for an average property paying an average price for IVOMEC EPRINEX and are based on trial data generated from effective treatment at or around calving.